| 000 | 01763 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518044012.0 | ||
| 264 | 0 | _c20200305 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1872-8332 | ||
| 024 | 7 |
_a10.1016/j.lungcan.2019.05.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDegens, J H R J | |
| 245 | 0 | 0 |
_aThe prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _c07 2019 |
||
| 300 |
_a130-135 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAdipose Tissue _xdiagnostic imaging |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aAtrophy |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdiagnostic imaging |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
| 700 | 1 | _aSanders, K J C | |
| 700 | 1 | _ade Jong, E E C | |
| 700 | 1 | _aGroen, H J M | |
| 700 | 1 | _aSmit, E F | |
| 700 | 1 | _aAerts, J G | |
| 700 | 1 | _aSchols, A M W J | |
| 700 | 1 | _aDingemans, A-M C | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 133 _gp. 130-135 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lungcan.2019.05.021 _zAvailable from publisher's website |
| 999 |
_c29800059 _d29800059 |
||